# Aardvark Therapeutics, Inc.: Form 8-K, filed Aug 11, 2026

- Company: [Aardvark Therapeutics, Inc.](/companies/aard.md) (CIK 1774857)
- Form: 8-K
- Filed: 2026-08-11
- Accepted by EDGAR: Aug 11, 2026, 21:05 ET
- Period: 2026-08-11
- Accession: 0001193125-26-344978
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1774857/000119312526344978/ck0001774857-20260811.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1774857/000119312526344978/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1774857/000119312526344978/ck0001774857-20260811.htm

Filed Aug 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-344978. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.